Literature DB >> 27338716

Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries.

Konstantinos E Farsalinos1,2, Konstantinos Poulas3, Vassilis Voudris1, Jacques Le Houezec4,5.   

Abstract

AIMS: To assess prevalence of electronic cigarette (e-cigarette) use, reported changes in smoking status due to e-cigarette use and correlates of e-cigarette use in the European Union (EU) member states in 2014.
DESIGN: Cross-sectional survey of EU citizens representative of the population (Special Eurobarometer 429).
SETTING: All 28 Member States of the EU. PARTICIPANTS: A total of 27 460 EU citizens aged ≥ 15 years (after excluding those who responded 'Do not know' to the questions about smoking status and e-cigarette use). MEASUREMENTS: Descriptive analysis [%, 95% confidence interval (CI)] of e-cigarette use prevalence (current use, past use and past experimentation) according to smoking status, self-reported changes in smoking status according to patterns of e-cigarette use and logistic regression analysis to examine correlates of e-cigarette use, especially socio-demographic factors and smoking status.
FINDINGS: Ever e-cigarette use was reported by 31.1% (95% CI = 30.0-32.2%) of current smokers, 10.8% (95% CI = 10.0-11.7%) of former smokers and 2.3% (95% CI = 2.1-2.6%) of never smokers. Past experimentation [7.2% (95% CI = 6.9-7.5%)] was more common than current [1.8% (95% CI = 1.6-1.9%)] and past use [2.6% (95% CI = 2.4-2.8%)]. Extrapolated to the whole population, approximately 48.5 million EU citizens were ever e-cigarette users, with 76.8% using nicotine-containing e-cigarettes. An estimated 6.1 and 9.2 million EU citizens had quit and reduced smoking with the help of e-cigarettes, respectively. Initiation with e-cigarettes was reported by 0.8% (95% CI = 0.6-0.9%) of participants who reported ever use of any tobacco-related product. Only 1.3% (95% CI = 1.1-1.5%) of never smokers used nicotine-containing e-cigarettes, with 0.09% (95% CI = 0.04-0.14%) reporting daily nicotine use. Smoking cessation with the help of e-cigarettes was reported by 35.1% (95% CI = 30.7-39.5%) of current e-cigarette users, while a further 32.2% (95% CI = 29.9-36.5%) reported smoking reduction. Being current [odds ratio (OR) = 21.23, 95% CI = 18.32-24.59) or former smokers (OR = 6.49, 95% CI = 5.49-7.67) were the strongest correlates of ever e-cigarette use.
CONCLUSIONS: E-cigarette use in the European Union appears to be largely confined to current or former smokers, while current use and nicotine use by people who have never smoked is rare. More than one-third of current e-cigarette users polled reported smoking cessation and reduction.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  Electronic cigarettes; European Union; nicotine; smoking; smoking cessation; tobacco

Mesh:

Year:  2016        PMID: 27338716     DOI: 10.1111/add.13506

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  56 in total

1.  Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys.

Authors:  Gary Chan; Kylie Morphett; Coral Gartner; Janni Leung; Hua-Hie Yong; Wayne Hall; Ron Borland
Journal:  Addiction       Date:  2019-01-21       Impact factor: 6.526

2.  Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey.

Authors:  Konstantinos E Farsalinos; Konstantinos Poulas; Vassilis Voudris; Jacques Le Houezec
Journal:  Intern Emerg Med       Date:  2017-03-04       Impact factor: 3.397

Review 3.  The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects.

Authors:  Matthew C Fadus; Tracy T Smith; Lindsay M Squeglia
Journal:  Drug Alcohol Depend       Date:  2019-05-23       Impact factor: 4.492

4.  Electronic cigarette use and smoking initiation among youth: a longitudinal cohort study.

Authors:  David Hammond; Jessica L Reid; Adam G Cole; Scott T Leatherdale
Journal:  CMAJ       Date:  2017-10-30       Impact factor: 8.262

Review 5.  Cardiovascular effects of electronic cigarettes.

Authors:  Neal L Benowitz; Joseph B Fraiman
Journal:  Nat Rev Cardiol       Date:  2017-03-23       Impact factor: 32.419

6.  E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries.

Authors:  Margarete C Kulik; Nadra E Lisha; Stanton A Glantz
Journal:  Am J Prev Med       Date:  2018-02-12       Impact factor: 5.043

7.  The role of E-liquid vegetable glycerin and exhaled aerosol on cue reactivity to tank-based electronic nicotine delivery systems (ENDS).

Authors:  Ashley Vena; Meghan Howe; Dingcai Cao; Andrea King
Journal:  Psychopharmacology (Berl)       Date:  2019-02-22       Impact factor: 4.530

8.  Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey.

Authors:  Shannon Gravely; James F Thrasher; K Michael Cummings; Janine Ouimet; Ann McNeill; Gang Meng; Eric N Lindblom; Ruth Loewen; Richard J O'Connor; Mary E Thompson; Sara C Hitchman; David Hammond; Bryan W Heckman; Ron Borland; Hua-Hie Yong; Tara Elton-Marshall; Maansi Bansal-Travers; Coral Gartner; Geoffrey T Fong
Journal:  Addiction       Date:  2019-03-07       Impact factor: 6.526

9.  Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.

Authors:  Richard J O'Connor; Brian V Fix; Ann McNeill; Maciej L Goniewicz; Maansi Bansal-Travers; Bryan W Heckman; K Michael Cummings; Sara Hitchman; Ron Borland; David Hammond; David Levy; Shannon Gravely; Geoffrey T Fong
Journal:  Addiction       Date:  2019-04-30       Impact factor: 6.526

10.  Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.

Authors:  Tracy T Smith; Dorothy K Hatsukami; Neal L Benowitz; Suzanne M Colby; F Joseph McClernon; Andrew A Strasser; Jennifer W Tidey; Cassidy M White; Eric C Donny
Journal:  Prev Med       Date:  2018-03-29       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.